 Anika Therapeutics NASDAQ:ANIK was upgraded by stock analysts at BidaskClub from a hold rating to a buy rating in a research note issued on Friday, BidAskClub reports. Several other research firms have also recently weighed in on ANIK. Barrington Research cut shares of Anika Therapeutics from an outperform rating to a market perform rating in ... 